Hong Kong’s HutchMed nets $537m from third IPO
Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: